Patients with KRAS mutant cancers are shown to have microbiomes with a higher abundance of Roseburia, Parabacteroides, Staphylococcus, and Staphylococcaceae than patients with non-mutant KRAS cancers, suggesting that interplay between microbial and mutational profiles influences cancer development [82]. The gene discussed is KRAS; the disease is cancer.